Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5774)	2/28/2002 11:03:24 AM
From: tuck	Respond to of 52153

Anybody, want to comment on why we haven't heard from MEDI or BTRN regarding the 507 data that was presented at the AAD meeting, now over? If the drug is that good, you'd think they'd say something. I presume certain investment banks have the info via attending consultants -- and the info is uninspiring, since the stocks haven't moved much -- but the public has not heard from those companies that have not done a PR. To my knowledge, there is no way of getting hold of the posters/abstracts. Abgenix and their IL-8 related drug, I can understand. Few are expecting stellar results from it. Cheers, Tuck